ALLERGEN IMMUNOTHERAPY DECREASES INTERLEUKIN-4 PRODUCTION IN CD4+ T-CELLS FROM ALLERGIC INDIVIDUALS

被引:501
作者
SECRIST, H [1 ]
CHELEN, CJ [1 ]
WEN, Y [1 ]
MARSHALL, JD [1 ]
UMETSU, DT [1 ]
机构
[1] STANFORD UNIV,DEPT PEDIAT,RM H307,STANFORD,CA 94305
关键词
D O I
10.1084/jem.178.6.2123
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Allergen specific CD4+ T cell clones generated from allergic individuals have been shown to produce increased levels of the cytokine interleukin 4 (IL-4), compared to allergen specific clones generated from nonallergic individuals. This difference between CD4+ T cells from allergic and nonallergic individuals with regard to cytokine production in response to allergen is thought to be responsible for the development of allergic disease with increased IgE synthesis in atopic individuals. We examined the production of IL-4 in subjects with allergic rhinitis and in allergic individuals treated with allergen immunotherapy, a treatment which involves the subcutaneous administration of increasing doses of allergen and which is highly effective and beneficial for individuals with severe allergic rhinitis. We demonstrated that the quantity of IL-4 produced by allergen specific memory CD4+ T cells from allergic individuals could be considerably reduced by in vivo treatment with allergen (allergen immunotherapy). Immunotherapy reduced IL-4 production by allergen specific CD4+ T cells to levels observed with T cells from non-allergic subjects, or to levels induced with nonallergic antigens such as tetanus toxoid. In most cases the levels of IL-4 produced were inversely related to the length of time on immunotherapy. These observations indicate that immunotherapy accomplishes its clinical effects by reducing IL-4 synthesis in allergen specific CD4+ T cells. In addition, these observations indicate that the cytokine profiles of memory CD4+ T cells can indeed be altered by in vivo therapies. Thus, the cytokine profiles of memory CD4+ T cells are mutable, and are not fixed as had been suggested by studies of murine CD4+ memory T cells. Finally, treatment of allergic diseases with allergen immunotherapy may be a model for other diseases which may require therapies that alter inappropriate cytokine profiles of memory CD4+ T cells.
引用
收藏
页码:2123 / 2130
页数:8
相关论文
共 41 条
  • [1] DIFFERENCES IN CLINICAL AND IMMUNOLOGICAL REACTIVITY OF PATIENTS ALLERGIC TO GRASS POLLENS AND TO MULTIPLE-POLLEN SPECIES .2. EFFICACY OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, SPECIFIC IMMUNOTHERAPY WITH STANDARDIZED EXTRACTS
    BOUSQUET, J
    BECKER, WM
    HEJJAOUI, A
    CHANAL, I
    LEBEL, B
    DHIVERT, H
    MICHEL, FB
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (01) : 43 - 53
  • [2] ANTIBODY TO INTERLEUKIN-5 INHIBITS HELMINTH-INDUCED EOSINOPHILIA IN MICE
    COFFMAN, RL
    SEYMOUR, BWP
    HUDAK, S
    JACKSON, J
    RENNICK, D
    [J]. SCIENCE, 1989, 245 (4915) : 308 - 310
  • [3] DOSE-RESPONSE OF IGE AND IGG ANTIBODIES DURING RAGWEED IMMUNOTHERAPY
    CRETICOS, PS
    VANMETRE, TE
    MARDINEY, MR
    ROSENBERG, GL
    NORMAN, PS
    ADKINSON, NF
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (01) : 94 - 104
  • [4] INDUCTION OF HUMAN IGE SYNTHESIS BY CD-4+ T-CELL CLONES - REQUIREMENT FOR INTERLEUKIN-4 AND LOW-MOLECULAR WEIGHT B-CELL GROWTH-FACTOR
    DEKRUYFF, RH
    TURNER, T
    ABRAMS, JS
    PALLADINO, MA
    UMETSU, DT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) : 1477 - 1493
  • [5] DEKRUYFF RH, 1992, J IMMUNOL, V149, P3468
  • [6] DEKRUYFF RH, 1989, J IMMUNOL, V142, P2575
  • [7] PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION
    DELPRETE, GF
    DECARLI, M
    MASTROMAURO, C
    BIAGIOTTI, R
    MACCHIA, D
    FALAGIANI, P
    RICCI, M
    ROMAGNANI, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) : 346 - 350
  • [8] DURHAM SR, 1992, J IMMUNOL, V148, P2390
  • [9] EFFECT OF IMMUNOTHERAPY ON HUMORAL AND CELLULAR RESPONSES IN RAGWEED HAYFEVER
    EVANS, R
    PENCE, H
    KAPLAN, H
    ROCKLIN, RE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (05) : 1378 - 1385
  • [10] REGULATION OF MURINE INVIVO IGG AND IGE RESPONSES BY A MONOCLONAL ANTI-IL-4 RECEPTOR ANTIBODY
    FINKELMAN, FD
    URBAN, JF
    BECKMANN, MP
    SCHOOLEY, KA
    HOLMES, JM
    KATONA, IM
    [J]. INTERNATIONAL IMMUNOLOGY, 1991, 3 (06) : 599 - 607